Influence of HLA-C expression level on HIV control.
dc.contributor.author | Apps, Richard | |
dc.contributor.author | Qi, Ying | |
dc.contributor.author | Carlson, Jonathan M | |
dc.contributor.author | Chen, Haoyan | |
dc.contributor.author | Gao, Xiaojiang | |
dc.contributor.author | Thomas, Rasmi | |
dc.contributor.author | Yuki, Yuko | |
dc.contributor.author | Del Prete, Greg Q | |
dc.contributor.author | Goulder, Philip | |
dc.contributor.author | Brumme, Zabrina L | |
dc.contributor.author | Brumme, Chanson J | |
dc.contributor.author | John, Mina | |
dc.contributor.author | Mallal, Simon | |
dc.contributor.author | Nelson, George | |
dc.contributor.author | Bosch, Ronald | |
dc.contributor.author | Heckerman, David | |
dc.contributor.author | Stein, Judy L | |
dc.contributor.author | Soderberg, Kelly A | |
dc.contributor.author | Moody, M Anthony | |
dc.contributor.author | Denny, Thomas N | |
dc.contributor.author | Zeng, Xue | |
dc.contributor.author | Fang, Jingyuan | |
dc.contributor.author | Moffett, Ashley | |
dc.contributor.author | Lifson, Jeffrey D | |
dc.contributor.author | Goedert, James J | |
dc.contributor.author | Buchbinder, Susan | |
dc.contributor.author | Kirk, Gregory D | |
dc.contributor.author | Fellay, Jacques | |
dc.contributor.author | McLaren, Paul | |
dc.contributor.author | Deeks, Steven G | |
dc.contributor.author | Pereyra, Florencia | |
dc.contributor.author | Walker, Bruce | |
dc.contributor.author | Michael, Nelson L | |
dc.contributor.author | Weintrob, Amy | |
dc.contributor.author | Wolinsky, Steven | |
dc.contributor.author | Liao, Wilson | |
dc.contributor.author | Carrington, Mary | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2017-06-01T20:35:06Z | |
dc.date.available | 2017-06-01T20:35:06Z | |
dc.date.issued | 2013-04-05 | |
dc.description.abstract | A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant genome-wide effect on HIV control in European Americans and is also associated with the level of HLA-C expression. We characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. Increasing HLA-C expression was associated with protection against multiple outcomes independently of individual HLA allelic effects in both African and European Americans, regardless of their distinct HLA-C frequencies and linkage relationships with HLA-B and HLA-A. Higher HLA-C expression was correlated with increased likelihood of cytotoxic T lymphocyte responses and frequency of viral escape mutation. In contrast, high HLA-C expression had a deleterious effect in Crohn's disease, suggesting a broader influence of HLA expression levels in human disease. | |
dc.identifier | ||
dc.identifier | 340/6128/87 | |
dc.identifier.eissn | 1095-9203 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | American Association for the Advancement of Science (AAAS) | |
dc.relation.ispartof | Science | |
dc.relation.isversionof | 10.1126/science.1232685 | |
dc.subject | African Americans | |
dc.subject | Alleles | |
dc.subject | Amino Acid Sequence | |
dc.subject | Anti-Retroviral Agents | |
dc.subject | Crohn Disease | |
dc.subject | Gene Expression Regulation | |
dc.subject | HIV | |
dc.subject | HIV Infections | |
dc.subject | HLA-C Antigens | |
dc.subject | Humans | |
dc.subject | Immunodominant Epitopes | |
dc.subject | Molecular Sequence Data | |
dc.subject | Mutation | |
dc.subject | Peptide Fragments | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | T-Lymphocytes, Cytotoxic | |
dc.subject | Viral Load | |
dc.title | Influence of HLA-C expression level on HIV control. | |
dc.type | Journal article | |
duke.contributor.orcid | Moody, M Anthony|0000-0002-3890-5855 | |
pubs.author-url | ||
pubs.begin-page | 87 | |
pubs.end-page | 91 | |
pubs.issue | 6128 | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Duke Human Vaccine Institute | |
pubs.organisational-group | Immunology | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
pubs.organisational-group | Pediatrics | |
pubs.organisational-group | Pediatrics, Infectious Diseases | |
pubs.organisational-group | School of Medicine | |
pubs.publication-status | Published | |
pubs.volume | 340 |